METHODS FOR TREATING IMMUNE-MEDIATED DISEASES OF THE NERVOUS SYSTEM ADMINISTERING A COMPOUND COMPRISING AGENTS THAT INHIBIT PROKINETICIN RECEPTORS ACTIVITY
The invention relates to a compound comprising non-peptide prokineticin receptors antagonists and agents that modulate or inhibit the activity of prokineticin receptors for use in the treatment of immune-mediated diseases of the central nervous system, peripheral nervous system and neuromuscular junctions.